- Report
- September 2026
- 197 Pages
Global
From €3227EUR$3,545USD£2,777GBP
€3586EUR$3,939USD£3,086GBP
- Report
- September 2026
- 354 Pages
Global
From €5325EUR$5,850USD£4,583GBP
- Report
- February 2026
- 250 Pages
Global
From €4087EUR$4,490USD£3,517GBP
- Report
- May 2026
- 185 Pages
Global
From €4096EUR$4,500USD£3,525GBP
- Report
- August 2026
- 110 Pages
Global
From €4324EUR$4,750USD£3,721GBP
- Report
- August 2026
- 160 Pages
Global
From €3022EUR$3,320USD£2,601GBP
€3778EUR$4,150USD£3,251GBP
- Report
- October 2025
- 87 Pages
United States
From €4096EUR$4,500USD£3,525GBP
- Report
- November 2025
- 150 Pages
Global
From €5416EUR$5,950USD£4,661GBP
- Report
- September 2026
- 186 Pages
Global
From €3227EUR$3,545USD£2,777GBP
€3586EUR$3,939USD£3,086GBP
- Report
- September 2026
- 189 Pages
Global
From €3227EUR$3,545USD£2,777GBP
€3586EUR$3,939USD£3,086GBP
- Report
- January 2026
- 180 Pages
Global
From €3227EUR$3,545USD£2,777GBP
€3586EUR$3,939USD£3,086GBP
- Report
- September 2026
- 187 Pages
Global
From €5325EUR$5,850USD£4,583GBP
- Report
- February 2026
- 250 Pages
Global
From €4087EUR$4,490USD£3,517GBP
- Report
- July 2026
- 200 Pages
Global
From €7273EUR$7,990USD£6,259GBP
- Report
- July 2026
- 200 Pages
Global
From €7273EUR$7,990USD£6,259GBP
- Report
- November 2025
- 150 Pages
Global
From €4415EUR$4,850USD£3,799GBP
- Report
- April 2026
- 160 Pages
Global
From €3022EUR$3,320USD£2,601GBP
€3778EUR$4,150USD£3,251GBP
- Report
- May 2025
- 150 Pages
Global
From €5416EUR$5,950USD£4,661GBP
- Report
- May 2024
- 129 Pages
Global
From €2730EUR$2,999USD£2,349GBP
€3640EUR$3,999USD£3,133GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1138EUR$1,250USD£979GBP

The Intravenous Iron market is a segment of the Hematological Drugs market, which includes drugs used to treat anemia and other blood disorders. Intravenous Iron is a type of drug used to treat iron deficiency anemia, a condition in which the body does not have enough iron to produce healthy red blood cells. Intravenous Iron is administered directly into the bloodstream, allowing for a more rapid increase in iron levels than oral iron supplements.
Intravenous Iron is used in a variety of settings, including hospitals, clinics, and home care. It is often prescribed to patients who are unable to take oral iron supplements due to gastrointestinal issues or who require a more rapid increase in iron levels.
The Intravenous Iron market is highly competitive, with a number of companies offering products in this space. Some of the major players in the market include Vifor Pharma, Fresenius Kabi, American Regent, and B. Braun. Show Less Read more